Index of artpub/2023/303439/

Strober, B
Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis : Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial
2023
https://ddd.uab.cat/record/303439